Video

Dr. Gill explains the importance of BPH treatment innovations to urology

Author(s):

Urology Times staff

“It’s pretty clear that over the past 50 years we've seen innovations in BPH treatment both from the utilization of technology and also from the patient outcome and experience standpoint,” says Bradley Gill, MD, MS.

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Bradley Gill, MD, MS discusses the importance of the new wave of minimally invasive BPH treatments for both patients and clinicians. Gill is a urologist with Glickman Urological & Kidney Institute at Cleveland Clinic.

Related Videos
Ravi Munver, MD, answers a question during a Zoom video interview
Raevti Bole, MD, answers a question during a video interview
Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Petar Bajic, MD, answers a question during a video interview
Raevti Bole, MD, answers a question during a video interview
Ravi Munver, MD, answers a question during a Zoom video interview
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Related Content
Phase 1/2 trial launches of Focal One robotic HIFU for BPH
October 9th 2024

Phase 1/2 trial launches of Focal One robotic HIFU for BPH

Hannah Clarke
“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the urethra and other critical structures," says Ryan Rhodes.
Dr. Schwen on focal therapies for prostate cancer
January 11th 2024

Dr. Schwen on focal therapies for prostate cancer

Cleveland Clinic
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
Survey reveals generational trends in men’s health habits
September 5th 2024

Survey reveals generational trends in men’s health habits

Hannah Clarke
“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.
male patient sitting in clinic room while doctor talks with him
May 23rd 2023

Dr. Gange discusses data on the UroLift System for BPH

Urology Times staff
The data were presented at the recent American Urological Association Annual Meeting.
AUA, GURS, SUFU amend guideline for incontinence after prostate treatment
July 10th 2024

AUA, GURS, SUFU amend guideline for incontinence after prostate treatment

Hannah Clarke
The guideline includes 38 recommendations on managing incontinence following treatment for localized prostate cancer or benign prostatic hyperplasia.
Aquablation granted new category I CPT code for BPH management
June 18th 2024

Aquablation granted new category I CPT code for BPH management

Hannah Clarke
The new Category I code will become effective on January 1, 2026.
© 2024 MJH Life Sciences

All rights reserved.